Loading chat...

NJ S2035

Bill

Status

Introduced

3/16/2020

Primary Sponsor

Troy Singleton

Click for details

Origin

Senate

2020-2021 Regular Session

AI Summary

Legislative Description

Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.

Substituted by another Bill

Last Action

Substituted by A277 (1R)

6/3/2021

Committee Referrals

Health, Human Services and Senior Citizens3/16/2020

Full Bill Text

No bill text available